Treatment of stage IIIb light chain amyloidosis according to Mayo
CO20260013842A2Pending Publication Date: 2026-10-08ALEXION PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CO20260013842
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-03-14
- Filing Date
- 2026-09-21
- Publication Date
- 2026-10-08
Abstract
The disclosure refers to methods for decreasing the amount of amyloid deposits in a subject with Mayo stage IIIb light chain amyloidosis (AL).
Need to check novelty before this filing date? Find Prior Art